Testing effectiveness (Phase 2)Study completedNCT00703391
What this trial is testing
A Two Week Study to Assess the Tolerability of AZD9668 in Chronic Obstructive Pulmonary Disease (COPD) Patients
Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 18